SEC Form 4 · accession 0001209191-18-006467
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susanna Gatti High
Officer — Chief Operating Officer
Period of report
Jan 30, 2018
Accepted (ET)
Feb 1, 2018 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 30, 2018 | M | 14,794 | $68.65 | A | 28,512 | D | |
| Common StockF2 | Jan 30, 2018 | S | 800 | $192.4927 | D | 27,712 | D | |
| Common StockF3 | Jan 30, 2018 | S | 3,703 | $193.7439 | D | 24,009 | D | |
| Common StockF4 | Jan 30, 2018 | S | 4,657 | $194.6525 | D | 19,352 | D | |
| Common StockF5 | Jan 30, 2018 | S | 2,039 | $195.5667 | D | 17,313 | D | |
| Common StockF6 | Jan 30, 2018 | S | 1,702 | $196.6339 | D | 15,611 | D | |
| Common StockF7 | Jan 30, 2018 | S | 1,385 | $197.6065 | D | 14,226 | D | |
| Common StockF8 | Jan 30, 2018 | S | 490 | $198.4634 | D | 13,736 | D | |
| Common StockF9 | Jan 30, 2018 | S | 697 | $199.4324 | D | 13,039 | D | |
| Common StockF10 | Jan 30, 2018 | S | 733 | $200.8812 | D | 12,306 | D | |
| Common StockF11 | Jan 30, 2018 | S | 770 | $201.5739 | D | 11,536 | D | |
| Common StockF12 | Jan 30, 2018 | S | 204 | $202.6801 | D | 11,332 | D | |
| Common StockF13 | Jan 30, 2018 | S | 82 | $203.60 | D | 11,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F14 | $68.65 | Jan 30, 2018 | M | 14,794 | A | — | Dec 1, 2026 | Common Stock | 14,794 | 45,206 | D |
Explanation of responses
- F1This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on December 18, 2017.
- F10The range in prices for the transaction reported on this line was $200.20 to $201.10. The average weighted price was $200.8812. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F11The range in prices for the transaction reported on this line was $201.30 to $202.05. The average weighted price was $201.5739. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F12The range in prices for the transaction reported on this line was $202.40 to $203.00. The average weighted price was $202.6801. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F13The range in prices for the transaction reported on this line was $203.50 to $203.70. The average weighted price was $203.60. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F14This option vests over a four-year period at a rate of twenty-five percent (25%) on November 30, 2017, and in 36 equal monthly installments thereafter.
- F2The range in prices for the transaction reported on this line was $192.00 to $192.95. The average weighted price was $192.4927. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $193.10 to $194.05. The average weighted price was $193.7439. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range in prices for the transaction reported on this line was $194.10 to $195.05. The average weighted price was $194.6525. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range in prices for the transaction reported on this line was $195.10 to $196.05. The average weighted price was $195.5667. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range in prices for the transaction reported on this line was $196.10 to $197.05. The average weighted price was $196.6339. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range in prices for the transaction reported on this line was $197.10 to $198.00. The average weighted price was $197.6065. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8The range in prices for the transaction reported on this line was $198.10 to $199.00. The average weighted price was $198.4634. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F9The range in prices for the transaction reported on this line was $199.10 to $200.05. The average weighted price was $199.4324. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.